Feburas Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and the formation of uric acid crystals in joints and tissues, which cause inflammation and pain. Feburas is typically prescribed for adults with chronic gout who have not responded adequately to other urate-lowering therapies or who are intolerant to them. The tablet should be taken orally, usually once daily, with or without food, as directed by a healthcare professional. It is important to maintain adequate hydration while on this medication to help prevent kidney stones. Patients should inform their doctor about any history of liver or kidney disease, cardiovascular conditions, or allergies before starting Feburas. Common side effects may include nausea, joint pain, rash, or liver enzyme abnormalities, and any unusual symptoms should be reported promptly. Regular monitoring of uric acid levels and liver function tests is recommended during treatment to ensure safety and efficacy. Feburas Tablet offers an effective option for long-term management of gout and hyperuricemia under medical supervision.